DataMeds AI regains compliance with Nasdaq minimum equity requirement
MEDS•DataMeds AI regained compliance with Nasdaq’s $2.5 million minimum stockholders’ equity requirement on October 19, 2026. The company remains subject to delisting if its next periodic report fails to demonstrate compliance.
1. Equity compliance restored
DataMeds AI regained compliance with Nasdaq’s $2.5 million minimum stockholders’ equity requirement on October 19, 2026. Nasdaq issued a delisting notice on April 13, 2026, citing bid-price and equity deficiencies; the company restored compliance with the $1 minimum bid-price requirement on June 9. It remains subject to delisting if its next periodic report fails to demonstrate compliance.
